There have been 15 recent insider transactions recorded for Ascendis Pharma A/S (ASND), including 0 buys and 0 sells.
Notable insiders with recent activity include Bienaime Jean Jacques, Mikkelsen Jan Moller, Cha Albert. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ASND
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-23 |
Bienaime Jean Jacques |
Director |
Unknown |
9,160 |
$172.35 |
$1.58M |
- |
| 2026-03-18 |
Mikkelsen Jan Moller |
Director |
Unknown |
28,945 |
- |
- |
- |
| 2026-03-18 |
Cha Albert |
Director |
Unknown |
1,930 |
- |
- |
- |
| 2026-03-18 |
Morrison Lisa |
Director |
Unknown |
1,930 |
- |
- |
- |
| 2026-03-18 |
Fairey William |
Director |
Unknown |
1,930 |
- |
- |
- |
| 2026-03-18 |
Imani Siham |
Director |
Unknown |
1,930 |
- |
- |
- |
| 2026-03-18 |
Smith Scott Thomas |
EVP & Chief Financial Officer |
Unknown |
9,552 |
- |
- |
- |
| 2026-03-18 |
Jensen Flemming Steen |
See Remarks |
Unknown |
9,552 |
- |
- |
- |
| 2026-03-18 |
Jensen Michael Wolff |
EVP, Chief Legal Officer |
Unknown |
9,552 |
- |
- |
- |
| 2026-03-18 |
Holtug Lars |
Director |
Unknown |
1,930 |
- |
- |
- |
| 2026-03-18 |
Sprogoe Kennett |
See Remarks |
Unknown |
9,552 |
- |
- |
- |
| 2026-03-18 |
Pedersen Anni Lotte Kirstine Sonderbjerg |
EVP & Chief Admin Officer |
Unknown |
9,552 |
- |
- |
- |
| 2026-03-18 |
Bodenhoff Mads |
SVP & Pao |
Unknown |
2,768 |
- |
- |
- |
| 2026-03-18 |
Shu Aimee |
EVP & Chief Medical Officer |
Unknown |
9,552 |
- |
- |
- |
| 2026-03-18 |
Wu Jay Donovan |
EVP & President Us Market |
Unknown |
9,553 |
- |
- |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
